Biology Reference
In-Depth Information
Mendelovic S, Doron A, Eilat E (1997) Short note: can depressive patients exploit the immune
system for suicide. Med Hypotheses 49:445-446
Mendelovic S, Doron A, Shoenfeld Y (1999) Depression and the immune system. Harefuah
136:88-91
Menniti FS, Faraci WS, Schmidt CJ (2006) Phosphodiesterases in the CNS: targets for drug
development. Nat Rev Drug Discov 5:660-670
Menniti FS, Chappie TA, Humphrey JM, Schmidt CJ (2007) Phosphodiesterase 10A inhibitors:
a novel approach to the treatment of the symptoms of schizophrenia. Curr Opin Investig Drugs
8:54-59
Meyer MR, Angele A, Kremmer E, Kaupp B, Muller F (2000) A cGMP-signaling pathway in
subset of olfactory sensory neurons. PNAS 97:10595-10600
Millar JK, Pickard BS, Mackie S, James R, Christie S, Buchanan SR (2005) DISCI and PDE4B
are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310:
1187-1191
Millar JK, Mackie S, Clapcote SJ, Murdoch H, Pickard BS, Christie S, Muir WJ, Blackwood DH,
Roder JC, Houslay MD, Porteous DJ (2007) Disrupted in schizophrenia 1 and phosphodiesterase
4B: towards an understanding of psychiatric illness. J Physiol 584:401-405
Miller CL, Oikawa M, Cai Y, Wojtovich AP, Nagel DJ, Xu X, Xu H, Florio V, Rybalkin SD,
Beavo JA, Chen YF, Li JD, Blaxall BC, Abe J, Yan C (2009) Role of Ca2+/calmodulin-
stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
Circ Res 105:956-964
Miro X, Perez-Torres S, Palacios JM, Puigdomenech P, Mengod G (2001) Differential distribution
of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs. Synapse 40:
201-204
Mir´ X, P´rez-Torres S, Puigdom`nech P, Palacios JM, Mengod G (2002) Differential distribution
of PDE4D splice variant mRNAs in rat brain suggests association with specific pathways and
presynaptical localization. Synapse 45:259-269
Miyamoto E (2006) Molecular mechanism of neuronal plasticity: induction and maintenance of
long-term potentiation in the hippocampus. J Pharmacol Sci 100:433-442
Molnar P, Gaal L (1992) Effect of different subtypes of cognition enhancers on longterm potenti-
ation in the rat dentate gyrus in vitro. Eur J Pharmacol 215:17-22
Monfort P, Mu˜oz MD, Kosenko E, Llansola M, S´nchez-P´rez A, Cauli O, Felipo V (2004)
Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading
phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of
hippocampus. Alterations in hyperammonemia. Neurochem Int. 2004 Nov;45(6):895-901
Monti B, Berteotti C, Contestabile A (2006) Subchronic Rolipram Delivery Activates Hippocam-
pal CREB and Arc, Enhances Retention and Slows Down Extinction of Conditioned Fear.
Neuropsychopharmacology 31:278-286
Mori F, P´rez-Torres S, De Caro R, Porzionato A, Macchi V, Beleta J, Gavald` A, Palacios JM,
Mengod G (2010) The human area postrema and other nuclei related to the emetic reflex
express cAMP phosphodiesterases 4B and 4D. J Chem Neuroanat 40:36-42
Mueller EM, Hofmann SG, Cherry JA (2010) The type IV phosphodiesterase inhibitor
rolipram disturbs expression and extinction of conditioned fear in mice. Neuropharmacology
59:1-8
Murata T, Shimizu K, Hiramoto K, Tagawa T, Murata T, Shimizu K, Hiramoto K, Tagawa T
(2009) Phosphodiesterase 3 (PDE3): structure, localization and function. Cardiovasc Hematol
Agents Med Chem 7:206-211
Murdoch H, Mackie S, Collins DM, Hill EV, Bolger GB, Klussmann E, Porteous DJ, Millar JK,
Houslay MD (2007) Isoform-selective susceptibility DISC1/phosphodiesterase-4 complexes to
dissociation by elevated intracellular cAMP levels. J Neurosci 27:9513-9524
Nagel DJ, Aizawa T, Jeon KI, Liu W, Mohan A, Wei H (2006) Role of nuclear Ca2+/calmodulin-
stimulated phos- phodiesterase 1A in vascular smooth muscle cell growth and survival. Circ
Res 98:777-784
